Peer Review History: Astemizole-Methylene Blue Combination Therapy Reduces Monotherapy Adverse Effects in Balb/C Mice

Editor(s):

(1) Dr. Takashi Ikeno, National Cancer Center Hospital East, Clinical Research Support Office, Japan.

Reviewers:

(1) Eman Ahmed Zaky, Ain Shams University, Egypt.

(2) Sirisha Goli, Kamineni Institute of Medical Sciences and Research Centre, India.

Additional Reviewers:

 

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8/10

Average Peer review marks at publication stage: 9/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Eman Ahmed Zaky, Egypt) | File 1 | File 2


Stage 2 | Peer review report_2 (Sirisha Goli, India) | File 1 | NA


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


Posted in Review History.